Delayed wound healing is a significant challenge for patients with Hypermobile Ehlers-Danlos Syndrome (hEDS), a connective tissue disorder characterized by joint hypermobility, skin fragility, and tissue laxity. The slow recovery process can lead to serious complications, as evidenced by common experiences such as issues with portacath incisions and wounds that fail to close properly. One major complication includes the need for additional sutures on portacath incisions due to adhesives like glue and tape failing to support wound closure long enough for proper healing. This can increase infection risk and discomfort for patients relying on frequent intravenous therapies. Another severe issue arises when repeated trauma, such as weekly port needle insertions, causes chronic skin damage to the point where holes develop over the port site, sometimes necessitating removal of the portacath. This disruption not only impacts treatment but also increases psychological distress. Moreover, delayed healing affects deeper tissues like the dura mater surrounding the spinal cord. Lumbar puncture procedures, commonly performed for diagnostic or therapeutic reasons, can result in cerebrospinal fluid (CSF) leaks leading to spinal headaches, a direct consequence of slow dura recovery in hEDS patients. Effective management involves a multidisciplinary approach focusing on wound care optimization, including the use of specialized dressings, advanced suturing techniques, and close monitoring to prevent infection and promote tissue regeneration. Patient education on protecting incision sites and recognizing early signs of complications is crucial. Awareness among healthcare providers about the unique healing challenges in hEDS is essential to tailor interventions appropriately and improve outcomes. Research into novel therapies targeting connective tissue integrity and regenerative medicine holds promise for better management of delayed wound healing in this population. Understanding these complications and adopting proactive strategies can significantly improve quality of life for individuals suffering from delayed wound healing associated with Hypermobile Ehlers-Danlos Syndrome.